Reed's Reports First Quarter 2023 Results
| REED'S, INC. | ||||||||
| CONDENSED STATEMENTS OF OPERATIONS | ||||||||
| For the Three Months Ended March 31, 2023 and 2022 | ||||||||
| (Unaudited) | ||||||||
| (Amounts in thousands, except share and per share amounts) | ||||||||
| March 31, 2023 | March 31, 2022 | |||||||
| Net Sales | $ | 11,157 | $ | 12,182 | ||||
| Cost of goods sold | 8,459 | 9,250 | ||||||
| Gross profit | 2,698 | 2,932 | ||||||
| Operating expenses: | ||||||||
| Delivery and handling expense | 2,120 | 2,812 | ||||||
| Selling and marketing expense | 1,447 | 2,178 | ||||||
| General and administrative expense | 1,709 | 2,121 | ||||||
| Total operating expenses | 5,276 | 7,111 | ||||||
| Loss from operations | (2,578 | ) | (4,179 | ) | ||||
| Interest expense | (1,779 | ) | (801 | ) | ||||
| Net loss | $ | (4,357 | ) | $ | (4,980 | ) | ||
| Net loss per share – basic and diluted | $ | (1.70 | ) | $ | (2.56 | ) | ||
| Weighted average number of shares outstanding – basic and diluted | 2,559,855 | 1,947,548 | ||||||
| REED'S, INC, | ||||||||
| CONDENSED BALANCE SHEETS | ||||||||
| (Amounts in thousands, except share amounts) | ||||||||
| March 31, | December 31, | |||||||
| 2023 | 2022 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | $ | 467 | $ | 533 | ||||
| Accounts receivable, net of allowance of $213 and $252, respectively | 4,665 | 5,671 | ||||||
| Inventory, net | 15,301 | 16,175 | ||||||
| Receivable from former related party | 777 | 777 | ||||||
| Prepaid expenses and other current assets | 601 | 939 | ||||||
| Total current assets | 21,811 | 24,095 | ||||||
| Property and equipment, net of accumulated depreciation of $867 and $787, respectively | 686 | 766 | ||||||
| Intangible assets | 626 | 626 | ||||||
| Total assets | $ | 23,123 | $ | 25,487 | ||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 11,165 | $ | 9,805 | ||||
| Accrued expenses | 467 | 233 | ||||||
| Revolving line of credit, net of capitalized financing costs of $322 and $363, respectively | 7,593 | 10,974 | ||||||
| Payable to former related party | 1,859 | 2,025 | ||||||
| Current portion of convertible notes payable, net of debt discount of $670 and $414, respectively | 5,485 | 2,434 | ||||||
| Current portion of lease liabilities | 194 | 187 | ||||||
| Total current liabilities | 26,763 | 25,658 | ||||||
| Convertible note payable, net of debt discount of $484 and $562, respectively, less current portion | 8,526 | 8,092 | ||||||
| Lease liabilities, less current portion | 156 | 207 | ||||||
| Total liabilities | 35,445 | 33,957 | ||||||
| Stockholders' deficit: | ||||||||
| Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding | 94 | 94 | ||||||
| Common stock, $.0001 par value, 180,000,000 shares authorized; 2,602,399 and 2,519,485 shares issued and outstanding, respectively | - | - | ||||||
| Additional paid in capital | 115,140 | 114,635 | ||||||
| Accumulated deficit | (127,556 | ) | (123,199 | ) | ||||
| Total stockholders' deficit | (12,322 | ) | (8,470 | ) | ||||
| Total liabilities and stockholders' deficit | $ | 23,123 | $ | 25,487 | ||||
| REED'S, INC. | ||||||||
| CONDENSED STATEMENTS OF CASH FLOWS | ||||||||
| For the Three Months Ended March 31, 2023 and 2022 | ||||||||
| (Unaudited) | ||||||||
| (Amounts in thousands) | ||||||||
| March 31, 2023 | March 31, 2022 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (4,357 | ) | $ | (4,980 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation | 47 | 25 | ||||||
| Amortization of debt discount | 281 | 65 | ||||||
| Amortization of prepaid financing costs | - | 431 | ||||||
| Fair value of vested options | 229 | 225 | ||||||
| Fair value of vested restricted shares granted to officers | 4 | 66 | ||||||
| Fair value of common shares issued as financing costs | - | 37 | ||||||
| Change in allowance for doubtful accounts | (39 | ) | 62 | |||||
| Inventory write-downs | (228 | ) | 10 | |||||
| Accrued interest | 1,113 | - | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | 1,044 | (40 | ) | |||||
| Inventory | 1,102 | (3,810 | ) | |||||
| Prepaid expenses and other assets | 338 | (617 | ) | |||||
| Decrease in right of use assets | 32 | 27 | ||||||
| Accounts payable | 1,360 | 5,926 | ||||||
| Accrued expenses | 235 | 403 | ||||||
| Lease liabilities | (44 | ) | (37 | ) | ||||
| Net cash provided by (used in) operating activities | 1,117 | (2,207 | ) | |||||
| Cash flows from investing activities: | ||||||||
| Net cash used in investing activities | - | - | ||||||
| Cash flows from financing activities: | ||||||||
| Proceeds from line of credit | 8,699 | 14,508 | ||||||
| Payments on line of credit | (12,120 | ) | (17,212 | ) | ||||
| Proceeds from convertible note payable, net of expenses | 2,405 | - | ||||||
| Proceeds from sale of common stock | - | 5,067 | ||||||
| Repurchase of common stock | (1 | ) | (2 | ) | ||||
| Amounts from former related party, net | (166 | ) | (81 | ) | ||||
| Net cash provided by (used in) financing activities | (1,183 | ) | 2,280 | |||||
| Net increase (decrease) in cash | (66 | ) | 73 | |||||
| Cash at beginning of period | 533 | 49 | ||||||
| Cash at end of period | $ | 467 | $ | 122 | ||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid for interest | $ | 390 | $ | 256 | ||||
Modified EBITDA
In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus, interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.
Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended March 31, 2023, and 2022 (unaudited; in thousands):
| Three Months Ended | ||||||||
| March 31 | ||||||||
| 2023 | 2022 | |||||||
| Net loss | $ | (4,357 | ) | $ | (4,980 | ) | ||
| Modified EBITDA adjustments: | ||||||||
| Depreciation and amortization | 80 | 52 | ||||||
| Interest expense | 1,779 | 801 | ||||||
| Stock option and other noncash compensation | 233 | 291 | ||||||
| Total EBITDA adjustments | $ | 2,092 | $ | 1,144 | ||||
| Modified EBITDA | $ | (2,265 | ) | $ | (3,836 | ) | ||
We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:
- Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs; Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment